$4.61
-0.55-10.66%
Last update: Nov 5, 5:33 PM
Kyverna Therapeutics Inc
KYTXNASDAQ
The average analyst price target for Kyverna Therapeutics is $21.67, 368.0% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $5 to $33. The latest change came on May 15, 2026, when HC Wainwright & Co. raised its price target on Kyverna Therapeutics from $20 to $25 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
